Jennifer J. Rhodes, See Remarks at Angion Biomedica Corp. (ANGN), sold 433 shares at $4.40 ($2K) on 2021-11-15, disclosed to the SEC on 2021-11-16.
Scheduled sale ($2k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ANGN | SELL | 2021-12-15 | $1K | — | Filing → |
| ANGN | SELL | 2021-10-15 | $4K | — | Filing → |
| ANGN | SELL | 2021-09-15 | $5K | — | Filing → |